Major Investment Made in 'Virtual Cell' Project for Biological Research
Google DeepMind, Meta, and Isomorphic Labs are jointly providing millions of dollars in funding for Biohub's virtual cell initiative.
Google DeepMind, Meta, and AI drug discovery startup Isomorphic Labs are investing $300 million into the Biohub initiative to build a 'virtual cell' model to be used in combating diseases.
Virtual Cell Initiative
Google DeepMind, Meta, and Isomorphic Labs have joined forces to develop a virtual cell model that will enable researchers to combat diseases. Under this partnership, a joint funding of $300 million is being channeled into the project.
Biohub and Foundation Work
The project in question is led by Biohub, a non-profit biomedical research organization founded by Mark Zuckerberg and his wife Priscilla Chan. Established in 2016, Biohub aims to prevent and treat diseases by creating a high-fidelity predictive model of the cell.
Comprehensive Funding
This effort forms part of a larger $1.8 billion virtual biology initiative aimed at building AI datasets that allow researchers to ask biological questions, make predictions, and receive answers in a digital environment.
Support from Public Institutions
To support the project, the U.S. Department of Energy will invest more than $500 million over the next five years. Additionally, the National Institutes of Health will contribute with datasets and knowledge bases derived from past federal investments.